8 Jul 2026 Drug CLASS II Dextroamphetamine Saccharate recalled by Lannett Company Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Lannett Packaging Defects Nationwide 24 Jun 2026 Drug CLASS III Focalin XR (dexmethylphenidate HCl) 5 mg recalled by Sandoz Focalin Sandoz Other Nationwide 27 May 2026 Drug CLASS II Atomoxetine Capsules HCL in unit dose foil strip, strips recalled Atomoxetine Safecor Health Labeling Errors TX 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 30 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 40 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 10 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 20 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 70 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 50 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 5 Nov 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 60 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 1 Oct 2025 Drug CLASS III Dextroamphetamine Saccharate recalled by Granules Pharmaceuticals Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Granules Pharmaceuticals Potency & Assay Nationwide 1 Oct 2025 Drug CLASS III Dextroamphetamine Saccharate recalled by Granules Pharmaceuticals Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Granules Pharmaceuticals Potency & Assay Nationwide 1 Oct 2025 Drug CLASS III Dextroamphetamine Saccharate recalled by Granules Pharmaceuticals Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Granules Pharmaceuticals Potency & Assay Nationwide 1 Oct 2025 Drug CLASS III Dextroamphetamine Saccharate recalled by Granules Pharmaceuticals Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Granules Pharmaceuticals Potency & Assay Nationwide 1 Oct 2025 Drug CLASS III Dextroamphetamine Saccharate recalled by Granules Pharmaceuticals Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Granules Pharmaceuticals Potency & Assay Nationwide 17 Sep 2025 Drug CLASS II Dextroamphetamine Saccharate, Amphetamine Aspartate recalled Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate Lannett Other OH 3 Sep 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 40 mg recalled by Lannett Lannett Packaging Defects Nationwide 23 Jul 2025 Drug CLASS II Lisdexamfetamine Dimesylate Capsules, 60 mg, CII recalled Lisdexamfetamine Dimesylate SUN Pharmaceutical Industries Potency & Assay Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 40 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 10 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 40 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 60 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 100 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 25 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 80 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 18 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 25 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 10 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 100 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide 26 Feb 2025 Drug CLASS II Atomoxetine Capsules, USP, 18 mg recalled by Glenmark Pharmaceuticals Atomoxetine Glenmark Pharmaceuticals Inc., USA Nitrosamine Impurity Nationwide